Stay updated on Pembrolizumab and Lenvatinib in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Lenvatinib in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Lenvatinib in Melanoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Locations have been added and updated across numerous regions worldwide, expanding the list of study sites. This expands enrollment access by giving participants more nearby sites and clearer site information.
    Difference
    4%
    Check dated 2025-12-23T20:22:43.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    47 days ago
    Change Detected
    Summary
    Added a new publication citation for LEAP-003 results (Ann Oncol. 2025) in Publications and updated the existing entry to Revision: v3.3.2 (from v3.2.0).
    Difference
    0.4%
    Check dated 2025-11-25T10:26:55.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    - Removed the government funding notice from the page. The notice previously warned that information may not be up to date due to funding lapses and directed users to opm.gov for updates.
    Difference
    0.2%
    Check dated 2025-11-18T06:50:53.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Added a Publications entry with a 2025 LEAP-003 study article citation and a Study Results section, and removed two older update dates (2025-10-17 and 2025-10-01).
    Difference
    0.4%
    Check dated 2025-11-03T20:36:50.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    Added a government operating status notice and updated version to v3.2.0; removed the previous v3.1.0 tag.
    Difference
    2%
    Check dated 2025-10-06T04:30:54.000Z thumbnail image
  9. Check
    104 days ago
    Change Detected
    Summary
    Appended version label (v3.1.0) and removal of multiple drug-safety related sections, indicating content consolidation and reorganization rather than new substantive content.
    Difference
    0.2%
    Check dated 2025-09-29T01:14:23.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Lenvatinib in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Lenvatinib in Melanoma Clinical Trial page.